References
Li L, Zhao X, Xiang B, Tang X. Ketorolac following mastectomy: is there an increased risk of reoperation? Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10071-5.
McCormick PJ, Assel M, Van Zee KJ, et al. Intraoperative ketorolac is associated with risk of reoperation after mastectomy: a single-center examination. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09722-4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Patrick McCormick - Dr McCormick’s spouse holds stock in Johnson & Johnson. Monica Morrow - Honoraria (Roche)
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
McCormick, P.J., Assel, M., Van Zee, K.J. et al. Reply to: “Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?”. Ann Surg Oncol 28 (Suppl 3), 777–778 (2021). https://doi.org/10.1245/s10434-021-10073-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10073-3